Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 50, 2020 - Issue 8
240
Views
3
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

CYP2C19 and CYP3A4 activity and ADP-induced platelet reactivity in prasugrel- or ticagrelor-treated STEMI patients: monocentric study in PRAGUE-18 trial participants

, ORCID Icon, , , , , & show all
Pages 929-938 | Received 12 Dec 2019, Accepted 14 Feb 2020, Published online: 30 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Vytenis Tamakauskas, Remigijus Žaliūnas, Vaiva Lesauskaitė, Nora Kupstytė-Krištaponė, Ieva Čiapienė, Gintarė Šakalytė, Jurgita Plisienė, Vilius Skipskis & Vacis Tatarūnas. (2024) The Effect of Platelet Activity, ABCB1 Genetic Polymorphism, and Renal Function on the Development of Ticagrelor-Related Dyspnea in Patients with Acute Coronary Syndrome. Drug Design, Development and Therapy 18, pages 109-119.
Read now

Articles from other publishers (2)

Hua Gao, Nan Yang, Libo Yang, Hui Wang, Guoshan Zhang, Xueping Ma & Ning Deng. (2023) Advances and Perspectives in methods for identifying high platelet reactivity. Heliyon 9:12, pages e22214.
Crossref
Qiufen Xie, Qian Xiang, Zhiyan Liu, Guangyan Mu, Shuang Zhou, Zhuo Zhang, Lingyue Ma, Yanjun Gong, Jie Jiang & Yimin Cui. (2022) Effect of CYP2C19 genetic polymorphism on the pharmacodynamics and clinical outcomes for patients treated with ticagrelor: a systematic review with qualitative and quantitative meta-analysis. BMC Cardiovascular Disorders 22:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.